This compound also had an antiproliferative effect in the nanomolar range (IC50 0.29 ± 0.02 μM, Table 4) on prostate cancer cell lines and, very interestingly, a downregulation effect on AR transcription, coupled with perturbation of some AR’s upstream transcription factors. The gene discussed is AR; the disease is prostate carcinoma.